Maintain pressure on reforms to protect NHSDiabetes gliclazide released in 40mg dose
A gliclazide for type 2 diabetes has been launched for the first time in a 40mg dose.
The product, launched under the name Zircon by Bristol Laboratories, allows patients to titrate up from the lowest possible dose without have to break 80mg tablets in half, which they previously had to do.
Have your say
You must sign in to make a comment.
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Readers' comments (1)
omar alqudah | 1-Jul-2010 6:59 am
NICE BUT I NEED MORE EXPLANATION ABOUT DIABETES MEDICINE
THANKS
Unsuitable or offensive?